Ontology highlight
ABSTRACT:
SUBMITTER: Ziogas IA
PROVIDER: S-EPMC5465010 | biostudies-literature | 2017 Jun
REPOSITORIES: biostudies-literature
Ziogas Ioannis A IA Tsoulfas Georgios G
World journal of clinical oncology 20170601 3
Hepatocellular carcinoma (HCC) is one of the most common malignant diseases worldwide and comes third in cancer-related mortality. Although there is a broad spectrum of treatment options to choose from, only a few patients are eligible candidates to receive a curative therapy according to their stage of disease, and thus palliative treatment is implemented in the majority of the patients suffering from liver cancer. Sorafenib, a multikinase inhibitor, is the only currently approved agent for sys ...[more]